JAG1 and cancer: CAR-T cells are genetically engineered T cells that carry major histocompatibility complex (MHC)-independent specific antigen (Ag) receptors and co-stimulatory molecules, and that can therefore induce an immune response against cells expressing cancer-associated Ags [3,4].